Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 332

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis

Open access
Suzuki, Reiko, Orsini, Nicola, Saji, Shigehira, Key, Timothy J., Wolk, Alicja·2009·International Journal of Cancer

Abstract

Epidemiological evidence indicates that the association between body weight and breast cancer risk may differ across menopausal status as well as the estrogen receptor (ER) and progesterone receptor (PR) tumor status. To date, no meta‐analysis has been conducted to assess the association between body weight and ER/PR defined breast cancer risk, taking into account menopausal status and study design. We searched MEDLINE for relevant studies published from January 1, 1970 through December 31, 2007. Summarized risk estimates with 95% confidence intervals (CIs) were calculated using a random‐effects model. The summarized results of 9 cohorts and 22 case‐control studies comparing the highest versus the reference categories of relative body weight showed that the risk for ER+PR+ tumors was 20% lower (95% CI = −30% to −8%) among premenopausal (2,643 cases) and 82% higher (95% CI = 55–114%) among postmenopausal (5,469 cases) women. The dose‐response meta‐analysis of ER+PR+ tumors showed that each 5‐unit increase in body mass index (BMI, kg/m 2) was associated with a 33% increased risk among postmenopausal women (95% CI = 20–48%) and 10% decreased risk among premenopausal women (95% CI = −18% to −1%). No associations were observed for ER−PR− or ER+PR− tumors. For discordant tumors ER+PR− (pre) and ER−PR+ (pre/post) the number of cases were too small (<200) to interpret results. The relation between body weight and breast cancer risk is critically dependent on the tumor's ER/PR status and the woman's menopausal status. Body weight control is the effective strategy for preventing ER+PR+ tumors after menopause. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.23943

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 332

Metadata

Authors
Suzuki, R., Orsini, N., Saji, S., Key, T. J., & Wolk, A.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2008-11-05
Volume
124
Issue
3
Pages
698-712
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2042328371
Cited by
332
References
58
FWCI
4.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis. https://app.cochat.ai/papers/10.1002/ijc.23943
The paper
Suzuki, R., Orsini, N., Saji, S., Key, T. J., & Wolk, A. (2009). Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.23943

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.